Object. Accurate localization of the subthalamic nucleus (STN) is important for proper placement of the elec trodes in deep brain stimulation (DBS) surgery for patients with advanced Parkinson disease. The authors evaluated the accuracy of our modified composite targeting method and the value of using high-field MR imaging for targeting the STN.
C hroniC DBS of the STN is an effective therapy for relief of motor symptoms associated with Parkin son disease. Inactivation of the motor territory of the STN 13 or the area immediately above the STN 19,37 al leviates parkinsonism, and accurate localization of the STN is important. However, the size and position of the STN is variable, 25 and it is sometimes difficult to localize this structure anatomically. 17, 32 Various imaging modali ties and targeting methods have been used to achieve sat isfactory clinical outcome. All commonly used imaging modalities, including MR imaging, 18, 23, 29 CT scanning, 27 and ventriculography, 10, 28 have been shown to be stereo tactically accurate, and no studies have substantiated the objective advantage of one of these modalities over any other. 24 Also, no clear advantage has been established A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation for direct or indirect targeting methods. 2, [4] [5] [6] 11, 12, 21, 24, 31, 36 Re cent advances in imaging modalities have refined the visualization of the STN 30 and other landmark structures. We hypothesized that the targeting accuracy can be im proved by use of high-field MR imaging and a modified composite targeting method. We compared the stereo tactic coordinates obtained using our composite targeting method with those of the standard targeting methods and compared surgical results of the 3T MR imaging-guided electrode implantation with those of 1.5T MR imagingguided surgery.
Methods

Patient Population
We reviewed and analyzed data obtained in 26 con secutive cases in which MR imaging was used to implant electrodes into the STN of patients with advanced Par kinson disease. Our institutional review board approved the study protocol, and written informed consent was obtained from all patients. The patients were randomly assigned to either the 3T MR imaging group (3T group) or 1.5T MR imaging group (1.5T group) based on the availability of the imaging units. Thirteen patients under went 3T MR imaging and 13 patients underwent 1.5T MR imaging preoperatively. All patients had experienced a definite improvement in motor symptoms in response to administration of levodopa. The clinical profiles of the patients are summarized in Table 1 . The mean scores (± SD) on the UPDRS Part III (motor subscale) were 39 ± 14 in the 3T group and 44 ± 15 in the 1.5T group during the offmedication period (all antiparkinsonian medica tions withheld overnight) and 24 ± 13 in the 3T group and 27 ± 14 in the 1.5T group during the onmedication period. The mean age of the patients at the time of sur gery was 58.7 years (range 40-69 years) in the 3T group and 61.5 years (range 49-72 years) in the 1.5T group. The symptoms were predominantly akinesia, rigidity, gait dysfunction, "on-off" fluctuations, and levodopa-induced dyskinesias or dystonias. The LEDD was calculated as reported. 22 Preoperative LEDD was 676 ± 191 mg in the 3T group and 691 ± 152 mg in the 1.5T group. Age, UP DRS Part III score, and LEDD of the 3T group and of the 1.5-T group were not significantly different (Table 1) . We implanted 52 electrodes and analyzed the data for each lead separately.
High-Field MR Imaging and Target Point Determination
On the day before surgery all patients underwent MR imaging. Axial and coronal T2weighted turbo spin echo images and axial Gdenhanced T1weighted 3D gradient echo images were obtained using a 3 or 1.5T MR im aging unit. Three different MR imaging units were used in this series, and sequence parameters are provided in Table 2 . We obtained a Gdenhanced 3D volumetric gra dient echo image set covering the entire brain in 2.0mm thick slices with a 0 interslice distance. Axial and coronal T2weighted turbo spin echo pulse sequence distance ac quired the slices through the targeted region in 2.0mm thick slices with a 0 interslice. 31 All preoperative targeting procedures were per formed using the surgical planning software (FrameLink, Medtronic Sofamor Danek). With identification of the AC, the PC, and the midline structures (the infundibulum, the aqueductus cerebri, and the falx cerebri), the loaded MR images were reconstructed to be parallel to the AC PC line and perpendicular to the midsagittal plane. The anatomical target for the STN was defined with the lat eromedial x coordinate, the anteroposterior y coordinate, and the superoinferior z coordinate using 3 methods of targeting: indirect targeting, red nucleus targeting, and modified composite targeting.
Indirect Targeting
The target was defined as 12 mm lateral, 2 mm pos terior, and 4 mm inferior to the MCP.
Red Nucleus-Based Targeting
According to the previously reported method, 4 the red nucleus-based target was defined with the x coordi nate 3 mm lateral to the most lateral border of the red nucleus and the y coordinate the same as that of the ante rior border of the red nucleus in the axial plane on the as sociated T2weighted axial image. The z coordinate was 2 mm inferior to the superior border of the red nucleus in the coronal plane. Contrast and gray scale were adjusted to improve the quality of the image without over contrast ing the red nucleus. 35 
Modified Composite Targeting
Considering interindividual variability in the po sitional relationship between the STN and the MCP or the red nucleus, we made a composite of and modified the previously reported methods to define the STN tar get. 4, 6, 20 Also, to reduce uncertainty in the process of determining the target, we sequentially referred to the 4 subcortical landmarks and pinpointed the target. The landmark structures for targeting the STN were the post mammillary commissure, the mammillothalamic tract, the red nucleus, and the anterior part of the STN, which is hypointense on T2weighted MR images 14 ( Fig. 1) . The stereotactic coordinate of each axis was determined as follows.
The z Coordinate. We identified the postmammillary commissure on a coronal T2weighted image (Fig. 1A) . The thin lamina of the postmammillary commissure was localized immediately anterior to the red nucleus on cor onal T2-weighted images. The z coordinate was defined at the midpoint of the postmammillary commissure and a cursor was placed to obtain an axial image at this z level for the following step (Fig. 1A) .
The x and y Coordinates. The axial T2weighted im age should show the red nucleus and mammillothalamic tract anterior to the red nucleus. The anterior part of the STN appears hypointense, and the posterior part of the nucleus is less hypointense anterolateral to the red nu cleus. 14 We defined the target point at the intersection of the anterior border of the red nucleus and the posterior border of the hypointense STN and determined the x and y coordinates accordingly (Fig. 1B) . We prioritized the modified composite target over the other targets in this study unless the modified composite target differed > 2 mm from other targets.
Entry Point Determination
The entry point was set at angle of 60° in the sagit tal projection and at angle of 15° lateral from the vertical line. We adjusted trajectory to avoid vessels, the cerebral sulci, or the lateral ventricle.
Surgical Procedures
Antiparkinsonian medications were withheld from patients for 12 hours before surgery to avoid medication induced dyskinesias during the procedure. On the morn ing of surgery, a stereotactic frame (Leksell G, Elekta Instruments) was pinned to the patient's cranium after application of a local anesthetic, taking care to align the frame with the midsagittal plane of the brain and with the ACPC line. Patients underwent stereotactic CT scan ning. We coregistered and superimposed the MR image onto the CT image to define the stereotactic coordinates for the anatomical target using the surgical planning software. Fusion was performed by using an automated technique based on a mutualinformation algorithm (Fra meLink) and was verified by the comparison of anatomi cal structures such as sulci, ventricles, mammillary bod ies, commissures, basilar and carotid arteries, lens of the eye, optic and trigeminal nerves, pineal gland, and cere bral aqueduct 16 to minimize fusion errors. 34 
Microelectrode Recording and Macrostimulation
Microelectrode recording was done with 4 microTar geting Microelectrodes (FHC), advanced in parallel using a multielectrode microdrive (Medtronic). Recordings of all 4 tracks were started 10 mm above the target and usu ally ended 3-4 mm below the target. All cellular activ ity were rated continuously with online analysis during electrode advancement, and were recorded using Lead point system (Medtronic) through all 4 tracks at intervals of 1 mm from 10 mm above the target and at intervals of 0.5 mm from 5 mm above the target. The electrophysi ological boundary of the STN was identified with spon taneous discharge frequency, irregular firing pattern, and an increase in background noise. 1, 8 The cells encountered during electrode advancement were assessed for its syn chronicity with passive movements. 1 The cells are con sidered to be movementrelated neurons if they show in * AC-PC = the length from the AC to the PC; off = off medication; on = on medication; 3rd V = the width of the third ventricle; UPDRS III = Part III (motor subscale) of the UPDRS. creased firing with the passive motion of the contralateral wrist, elbow, shoulder, hip, knee, or ankle. 1 The tracks with the typical STN activity with distance over 3.5 mm and with movementrelated neurons were assessed with macrostimulation. The microelectrodes of the selected tracks were retracted until their tips were hidden, and their macroelectrode contacts were placed on the dorsal margin of the STN according to the microelectrode re cording results. With macrostimulation at a frequency of 130 Hz, a pulse width of 0.1 msec, and an amplitude of 0.1 to 3-4 mA, neurologists assessed alleviation of rigid ity and tremor with appearance of side effects. Macro electrode contacts were advanced by 2 mm if it remained within the STN, and macrostimulation was repeated after the previous stimulation effects had subsided. The track with the best alleviation of rigidity and tremor and with least side effects was regarded as the optimum trajectory and determined the depth of placement for the DBS lead.
Deep Brain Stimulation Lead Placement
The microTargeting Microelectrode with the best macrostimulation result was replaced with a DBS lead (Models 3389 and 3387, Medtronic). The DBS lead was implanted according to macrostimulation result, and its position was verified using fluoroscopy. The lead was fi nally fixed in the bur hole ring and connected to an exten sion cable, which was connected to an implanted internal pulse generator (Model 7426 [Soletra Neurostimulator], Medtronic).
Measurement of Lead Location
The pulse sequences selected for postoperative 1.5T MR imaging unit were the same as those for preoperative MR imaging (Table 2) , and the parameters were adjusted to limit specific absorption rate to 0.1 W/kg or less ac cording to the manufacturer's instructions. Postoperative MR images were transferred and fused with the preop erative image in each patient using the surgical planning software. The center of the lead artifact was defined in the axial plane at the level of the z coordinate for the pre operative STN target. The distance from this center of the lead artifact to the midcommissural point was measured in the x and y axes and was compared with the coordi nates of the preoperative STN target. For evaluation of the z coordinate, the lowest point of the electrode artifact was identified and compared with the results of the elec trophysiological recording.
The midpoint of the clinically used contact of each DBS electrode was identified and plotted onto the micro electrode recording results in reference to the target point as zero.
Clinical Outcomes
The stimulation parameters were programmed in 2-3 weeks after surgery to wait until the microlesioning effect had subsided. Programming was usually performed while the patient was in the offmedication state. In most patients programming was conducted in a monopolar configura tion by using a single contact that had been placed in the dorsal STN or immediately above the STN, as confirmed by intraoperative observations. In cases in which monop olar stimulation induced side effects, bipolar stimulation was used. The frequency and pulse width were set at 130 Hz and 60 µsec. Voltage was titrated for clinical benefit over the initial months, usually to 2-3 V. Neurological as sessment was performed pre and postoperatively by neu rologists using the UPDRS and timed motor tests. Part III of the UPDRS was performed when the patient was in the off and onmedication states. The offmedication state was produced by withholding antiparkinsonian medica tion for 12 hours. Preoperative and postoperative LEDD was calculated as previously reported. 22 
Statistical Analysis
All data related to the surgical procedure, intraop erative physiological findings, lead locations, and clini cal outcomes were entered into a customized database. Statistical analyses were performed using JMP (SAS In stitute).
Analysis of the Coordinates
The framebased stereotactic coordinates of the red nucleus-based target and modified composite target were transformed into coordinates based on the MCP in Ta lairach space. Data from right and left sides were pooled together to increase the power of the sample. Differences along the individual x, y, and z axes were analyzed be tween red nucleus-based targeting coordinates and modi fied composite targeting coordinates with paired Student ttest. The null hypothesis was that there is no difference between the targets involving the modified composite and red nucleus-based targets.
Analysis of the Track and Other Parameters
The final trajectories were compared between the 3 and 1.5T groups with chisquare analysis. The STN length, pre and postoperative Part III UPDRS scores dur ing on and off periods, and pre and postoperative LEDD were compared between the 3 and 1.5T groups using the Student ttest. The null hypothesis was that there is no difference in the aforementioned parameters between the 2 imaging groups. Mean values are presented ± SD unless otherwise stated.
Results
Disparity Between the Modified Composite Method Target and the Red Nucleus-Based and MCP-Based Targets
The landmark structures were visualized clearly on the preoperative 3T MR images. The target points were determined using the indirect, red nucleus-based, and modified composite targeting methods in each patient. The mean lengths of the ACPC and the widths of the third ventricles were 24.3 ± 1.9 and 6.0 ± 1.3 mm in the 3T group and 23.8 ± 1.9 and 6.5 ± 2.0 mm in the 1.5T group, respectively (p = 0.23 and 0.21, respectively) (Ta ble 1).
In the 3T group, the mean position of the composite target point relative to the MCP was x = 11.0 ± 1.0 mm (maximum 12.8 mm; minimum 9.5 mm); y = 2.4 ± 1.0 mm (maximum 4.3 mm; minimum 1.0 mm); and z = 4.5 ± 0.5 mm (maximum 5.9 mm; minimum 3.6 mm). In the 1.5T group, the mean position of the composite target point relative to the MCP was x = 11.2 ± 0.9 mm (maxi mum 13.1 mm; minimum 9.2 mm); y = 2.0 ± 0.8 mm (maximum 3.5 mm; minimum 0.4 mm); and z = 4.7 ± 0.8 mm (maximum 6.3 mm; minimum 3.2 mm) ( Table 3) . The composite target was medial and inferior to the MCP target (p < 0.01) and the red nucleus target (p < 0.01) in both 3 and 1.5T groups. In addition, the composite tar get and the red nucleus target were posterior to the MCP target in the 3T group (p < 0.05). The composite target had a smaller variance in targeting the z coordinate in the 3T group.
Composite Method When Using 3-T MR Images To Define the Central Track as an Optimum Trajectory
According to the microelectrode recording results, the mean path length through the STN of the central track was 4.9 ± 1.1 mm (SEM 0.2 mm; maximum 7.0 mm; min imum 2.0 mm) in the 3T group and 3.1 ± 2.0 mm (SEM 0.4 mm; maximum 6.5 mm; minimum 0.0 mm) in the 1.5T group (p = 0.0001) (Fig. 2A) . The mean length of the longest path through the STN in any tracks was 5.1 ± 0.9 mm (SEM 0.2 mm; maximum 7.0 mm; minimum 4.0 mm) in the 3T group and 4.8 ± 0.9 mm (SEM 0.2 mm; maximum 6.5 mm; minimum 3.5 mm) in the 1.5T group (p = 0.18).
The mean positions of the dorsal end, the ventral end, and the midpoint of the subthalamic nucleus in the central track were −2.0 ± 1.4 mm (superior to the target; SEM 0.3 mm), +2.8 ± 1.7 mm (inferior to the target; SEM 0.3 mm), and +0.4 ± 1.4 mm (SEM 0.3 mm) in the 3T group, and −1.1 ± 1.7 mm (SEM 0.4 mm; p = 0.028), +2.4 ± 1.1 mm (SEM 0.2 mm; p = 0.16), and +0.6 ± 1.2 mm (SEM 0.3 mm; p = 0.27) in the 1.5T group, respectively (Fig. 2B) .
The tracks in which the STN path was > 3.5 mm were tested with macrostimulation. In the 3T group, 21 (81%) of 26 DBS electrodes were placed in the central track with 15% in the anterior and 4% in the lateral track (Fig. 2C) . In the 1.5T group, only 8 (31%) of 26 DBS electrodes were placed in the central track, whereas 42% of electrodes were in the lateral track, 19% in the ante rior track, and 8% in the posterior track. A chisquare test demonstrated a significant correlation between using composite targeting on 3T MR imaging and the accuracy of the central track (p = 0.006; Fig. 2C ).
The preoperative target (Fig. 3A) and the postopera tive lead location (Fig. 3B) were compared in the axial plane at the midpoint of the postmammillary commis sure parallel to ACPC line. The mean position of the lead location relative to the MCP was x = 10.9 ± 1.0 mm, y = 2.6 ± 1.1 mm, and z = 4.3 ± 0.4 mm in the 3T group and x = 11.7 ± 1.3 mm, y = 2.3 ± 1.1 mm, and z = 4.6 ± 0.7 mm in the 1.5T group ( Table 4 ). The postoperative lead was lateral to the preoperative target in the 1.5T group (p = 0.037). The dorsoventral location of the clinically used (active) contact was plotted onto the microelectrode recording data (Fig. 2B) 
Clinical Outcomes
Postoperative improvement of the UPDRS Part III score and reduction of LEDD were significant in both im aging groups ( Table 5 ). The mean postoperative UPDRS score was 17.4 ± 8.3 during the off period (p < 0.001) and 15.8 ± 7.6 during the on period (p = 0.008) in the 3T group and 25.8 ± 10.2 (p = 0.02) during the off period (p < 0.001) and 22.4 ± 9.3 (p = 0.03) during the on period in the 1.5T group. The mean postoperative LEDD was 363 ± 206 mg in the 3T group (p < 0.001) and 391 ± 234 mg in the 1.5T group (p < 0.001).
The reduction rates of these parameters were higher in the 3-T group than in the 1.5-T group but not signifi cantly so (Table 5 ). The mean reduction rate of UPDRS part III score was 53.0 ± 23.2% during the off period and 25.6 ± 23.2% during the on period in the 3T group and 41.0 ± 15.6% (p = 0.14) during the off period and 14.4 ± 13.0% (p = 0.14) during the on period in the 1.5T group. The mean reduction rate of LEDD was 48.6 ± 23.1% in the 3T group and 43.7 ± 25.2% in the 1.5T group (p = 0.61).
Postoperative complications included mood change in 2 patients in each group, deterioration of dopamine dysregulation syndrome in 1 patient in the 3T group, and humeral fracture due to a fall in a patient of the 3T group. None of the patients suffered postoperative hemorrhage or infection.
Discussion
In STN DBS surgery, the accuracy of the preopera tive targeting is important to achieve favorable surgical outcome. Imaging and coordinate determination are fun damental elements of the surgical planning. A few studies have examined the targeting accuracy of high-field MR imaging. 2, 30 Also, various targeting methods have been reported with their advantages. 2, [4] [5] [6] 11, 12, 21, 31, 36 In this study, the preoperative targeting was performed using a 3T MR imaging-based, modified composite targeting method. The individualized target in the 3T group was accept ably accurate, and the active electrodes were placed in the dorsal STN or immediately above the STN 19, 37 with satisfactory surgical outcome.
Magnetic resonance imaging of the STN is complex because of the structure's small size, lenticular shape, oblique orientation, and its uneven intensity.
14 On the axial T2weighted image obtained with various inversion recovery sequences, the STN corresponds to the T2 hy pointense area anterolateral to the red nucleus; however, the posterior part of the STN is frequently less hypoin tense due to its iron content intensity.
14 To overcome such difficulties in imaging the STN, a high-field MR imag ing system is an emerging option 26 with its advantages of high resolution and improved signaltonoise ratio and contrasttonoise ratio. Threetesla MR imaging has been used for the STN DBS surgery, and its contribution may 30 or may not 2 be significant. In the present study, the im proved visualization of the subcortical landmark struc tures on 3T MR imaging was useful for pinpoint target ing to the STN.
The methods for targeting the STN are classified into indirect and direct methods. 24 Indirect targeting is simple but not designed to accommodate individual variances. Direct targeting can be the most accurate method but is sometimes referred as a less accurate method. 4, 36 The red nucleus-based targeting is an intermediate method with satisfactory outcome, which determines the stereotactic coordinates by referring to the topography of the red nu cleus. 4, 6 We followed and modified the method by Bejjani et al. 6 in which 3T MR imaging is used. Slavin and colleagues' 30 direct targeting method with 3T MR imaging defines the target as the center of the STN. However, the STN is complex in shape and it is often difficult to determine the central point of the structure. To minimize the planreplan and interexaminer variance in the targeting procedure, we first define the working plane referring to ACPC, postmammillary commissure, 20 and mammillothalamic tract, and we subsequently define the target using the anterior border of the red nucleus and the posterior border of the T2weighted hypointense STN on the defined working plane. Two methods of red nucleusbased targeting, by Bejjani et al. 6 and by AndradeSouza et al., 4 are different in how the x coordinates are deter mined. Bejjani et al. referred to the hypointense T2 signal area anterolateral to the red nucleus, whereas Andrade Souza et al. determined the x coordinate at 3 mm lat eral to the lateral border of the red nucleus. The current method is similar to that used by Bejjani et al. and pin points the target by referring to the multiple landmarks. The result of our composite target showed that the final x coordinate was often within 3 mm of the lateral border of the red nucleus and slightly posterior and inferior to the MCP target.
The source of targeting inaccuracy includes the imaging errors, the interindividual variance, and the unknown issues. The imaging errors result from object image mismatch, 14, 15, 25, 30 distortion, motion artifact, and rotated frame fixation. Although high-field MR imaging may induce image distortion and be susceptible to motion artifact, these negative effects seemed to be negligible in this study. The interindividual variance of the STN to pography results in objectatlas mismatch. The current modified composite targeting corresponded to asymme try, mild atrophy, and various sizes of the brain and may minimize the error due to interindividual variance.
The multitrack microelectrode recording results
showed that accuracy of the compositebased targeting was acceptable. The central track of the defined target usually traversed the STN and was defined as the opti mum trajectory in most of the cases. Simultaneous mul tiple microelectrodes recording is performed using 3-5 electrodes. 3, 6, 33 The risk of complications is similar be tween single electrode surgery and simultaneous multiple electrodes surgery, 3, 7, 9 but using multiple electrodes may increase hemorrhage 3 and impair the cognitive function. 33 The current modified composite targeting method may be useful to reduce the number of recording tracks and to avoid additional adverse effects. Our method is rather simple, safe, accurate, and use ful to standardize the procedure. Although the use of an expensive modality remains a practically controver sial issue, further refinement of surgical methods would be necessary to maximize the therapeutic contributions and minimize the adverse effects of subthalamic nucleus DBS.
Conclusions
The modified composite targeting method involving high-field MR imaging is useful for defining the STN in patients with advanced Parkinson disease. The sequen tially defined stereotactic coordinates pinpoint the target at the crossing of the line passing the anterior border of red nucleus and the posterior border of the hypointense STN on the plane that is parallel to the ACPC line at the level of the midpoint of the postmammillary commissure. The defined target is individualized, acceptably accurate, and correlated with the postoperative clinical improve ment. 
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